ITEM 8.01 OTHER EVENTS.

As previously announced, on December 31, 2020, Pulse Biosciences, Inc. (the "Company") delivered a notice of redemption to redeem all of the outstanding warrants (the "Warrants") to purchase shares of the Company's common stock, $0.001 par value per share (the "Common Stock"), issued on June 16, 2020 in connection with the Company's rights offering pursuant to its Registration Statement on Form S-3, as amended (File No. 333-237577) and that remained unexercised on February 5, 2021 (the "Redemption Date"). Pursuant to the redemption, the Company redeemed 5,139 Warrants for a redemption price of $0.01 per Warrant. Prior to the Redemption Date, 636,432 Warrants were exercised, generating approximately $4.5 million of gross proceeds to the Company. As of February 9, 2021, the Company had outstanding 26,061,975 shares of Common Stock.




?

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses